NP and/or the HR guy discussed the social media aspect of CYDY in an email response to an investor. Their response was simply that they can’t advertise a drug that has yet to be approved. Yes, they can still tweet or link out videos and PRs, but I think you’re over estimating what social media can do for CYDY at this point. I don’t think any of the biotechs that I’ve invested in were heavy users of social media.